Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer (Q39727817)

14 September 2017

title

Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer (English)

1 reference

14 September 2017

A Ooki

1

1 reference

14 September 2017

K Yamashita

2

1 reference

14 September 2017

S Kikuchi

3

1 reference

14 September 2017

S Sakuramoto

4

1 reference

14 September 2017

N Katada

5

1 reference

14 September 2017

K Kokubo

6

1 reference

14 September 2017

H Kobayashi

7

1 reference

14 September 2017

M S Kim

8

1 reference

14 September 2017

D Sidransky

9

1 reference

14 September 2017

M Watanabe

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

15 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

22

1 reference

14 September 2017

page(s)

3263-3275

1 reference

Epidemiology of gastric cancer

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Epigenetic field for cancerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Quantitative assessment of DNA methylation: Potential applications for disease diagnosis, classification, and prognosis in clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Hop is an unusual homeobox gene that modulates cardiac development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Relevance of DNA methylation in the management of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Analysis of the structure and function of the transcriptional coregulator HOP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

The power and the promise of DNA methylation markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Impact of diagnostic laparoscopy on the management of gastric cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Quantitative hypermethylation of NMDAR2B in human gastric cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Gastric cancer treatment guidelines in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Molecular and cellular features of esophageal cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Aberrant methylation of Reprimo in human malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Biallelic inactivation of the RIZ1 gene in human gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

The role of PGP9.5 as a tumor suppressor gene in human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

PGP9.5 methylation in diffuse-type gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Clinical significance of tumor markers and an emerging perspective on colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Molecular staging of gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.76

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.76

1 reference

14 September 2017

1 reference